Answers are grounded in this paper and cite their sources.
treated with intravenous antibiotics. The manifestations were observed after 4 days of Polymyxin B therapy initiation. All other concomitant drugs, infections, or immunologic disorders that, could have caused this symptom, were carefully excluded. An objective causality assessment reveals that, the cutaneous hyperpigmentation was possibly associated with Polymyxin B therapy, though further studies may be needed to explain the underlying mechanism.
No takes yet. Share an insight, caveat, or question.
Sandeep Lahiry (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: